GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Johnson & Johnson (UKEX:JNJ) » Definitions » Shiller PE Ratio

Johnson & Johnson (UKEX:JNJ) Shiller PE Ratio : 21.68 (As of Apr. 30, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Johnson & Johnson Shiller PE Ratio?

As of today (2024-04-30), Johnson & Johnson's current share price is ₴5947.00. Johnson & Johnson's E10 for the quarter that ended in Dec. 2023 was ₴274.32. Johnson & Johnson's Shiller PE Ratio for today is 21.68.

The historical rank and industry rank for Johnson & Johnson's Shiller PE Ratio or its related term are showing as below:

UKEX:JNJ' s Shiller PE Ratio Range Over the Past 10 Years
Min: 19.28   Med: 25.92   Max: 33.32
Current: 20.3

During the past years, Johnson & Johnson's highest Shiller PE Ratio was 33.32. The lowest was 19.28. And the median was 25.92.

UKEX:JNJ's Shiller PE Ratio is ranked better than
59.05% of 525 companies
in the Drug Manufacturers industry
Industry Median: 24.85 vs UKEX:JNJ: 20.30

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Johnson & Johnson's adjusted earnings per share data for the three months ended in Dec. 2023 was ₴66.010. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is ₴274.32 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Johnson & Johnson Shiller PE Ratio Historical Data

The historical data trend for Johnson & Johnson's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Johnson & Johnson Shiller PE Ratio Chart

Johnson & Johnson Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 29.45 31.45 29.88 28.15 21.67

Johnson & Johnson Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24.91 26.23 21.48 21.67 -

Competitive Comparison of Johnson & Johnson's Shiller PE Ratio

For the Drug Manufacturers - General subindustry, Johnson & Johnson's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Johnson & Johnson's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Johnson & Johnson's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Johnson & Johnson's Shiller PE Ratio falls into.



Johnson & Johnson Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Johnson & Johnson's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=5947.00/274.32
=21.68

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Johnson & Johnson's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, Johnson & Johnson's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=66.01/129.4194*129.4194
=66.010

Current CPI (Dec. 2023) = 129.4194.

Johnson & Johnson Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 64.824 99.695 84.152
201406 59.685 100.560 76.814
201409 65.614 100.428 84.556
201412 35.179 99.070 45.956
201503 60.476 99.621 78.565
201506 63.638 100.684 81.800
201509 47.432 100.392 61.147
201512 45.456 99.792 58.951
201603 62.847 100.470 80.955
201606 56.523 101.688 71.937
201609 60.476 101.861 76.838
201612 54.547 101.863 69.303
201703 63.638 102.862 80.068
201706 55.337 103.349 69.296
201709 54.152 104.136 67.300
201712 -157.711 104.011 -196.237
201803 63.243 105.290 77.737
201806 57.314 106.317 69.768
201809 56.918 106.507 69.163
201812 44.270 105.998 54.052
201903 54.942 107.251 66.299
201906 82.215 108.070 98.457
201909 26.088 108.329 31.167
201912 59.290 108.420 70.774
202003 85.773 108.902 101.933
202006 53.756 108.767 63.963
202009 52.570 109.815 61.955
202012 25.692 109.897 30.256
202103 91.702 111.754 106.197
202106 92.888 114.631 104.871
202109 54.152 115.734 60.555
202112 69.962 117.630 76.974
202203 76.286 121.301 81.392
202206 71.148 125.017 73.654
202209 66.405 125.227 68.628
202212 52.570 125.222 54.332
202303 -1.186 127.348 -1.205
202306 77.472 128.729 77.888
202309 403.567 129.860 402.199
202312 66.010 129.419 66.010

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Johnson & Johnson  (UKEX:JNJ) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Johnson & Johnson Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Johnson & Johnson's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Johnson & Johnson (UKEX:JNJ) Business Description

Address
One Johnson and Johnson Plaza, New Brunswick, NJ, USA, 08933
Johnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women's health. The consumer group is being divested in 2023 under the new name Kenvue. Geographically, just over half of total revenue is generated in the United States.